Literature DB >> 5568780

Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog.

S F Sisenwine, H W Ruelius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5568780

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

2.  Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.

Authors:  L F Chasseaud; W H Down; R K Grundy
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

3.  First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.

Authors:  U Abshagen; S Spörl-Radun
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.

Authors:  T B Tzeng; H L Fung
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

5.  Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.

Authors:  U Abshagen; G Betzien; R Endele; B Kaufmann; G Neugebauer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.

Authors:  M D Gammage; R G Murray; W A Littler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Pharmacokinetics of intravenous isosorbide-dinitrate.

Authors:  R Platzer; G Reutemann; R L Galeazzi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.